Originally developed for type 2 diabetes management, these injectable medicines work by mimicking natural GLP-1 hormone, reducing appetite and caloric intake
Low blood sugar: A condition where blood sugar drops below normal levels, leading to symptoms like dizziness, sweating, and confusion
Across both routes of administration, gastrointestinal events dominate the side-effect profile of GLP-1 receptor agonists
For the study, postdoctoral scientist Chi Kin Wong, induced systemic inflammation in mice by either injecting them with a bacterial cell wall component or a bacterial slur to induce sepsis, an extensive inflammation throughout the body that leads to organ damage
Other diabetes medications Drugs like SGLT-2 inhibitors, like empagliflozin, or other GLP-1 agonists, like dulaglutide, may be appropriate choices for blood sugar regulation, Dr